Calendar RedHill Biopharma Ltd. TEL AVIV STOCK EXCHANGE

Equities

RDHL

IL0011223810

Delayed TEL AVIV STOCK EXCHANGE 5-day change 1st Jan Change
- ILa -.--% Intraday chart for RedHill Biopharma Ltd. -9.57% -17.72%

Chart calendar RedHill Biopharma Ltd.

a11ac9811429d83d827d1e99f783c8.PRxCi1LcDubpG271-_GruWjdFNPbPuNyBvIWInW9u0g.RyoHzmKvVoKYfB2ByYf-3V6sTomMbYImf8V-URnr9jkOe2_5Z69tjbYsHQ~e04bb74ade06c5c17e94e840f696845d

Upcoming events on RedHill Biopharma Ltd.

06/05/2024 Q1 2024 Earnings Release (Projected)
07/05/2024 16:00 Aegis Capital Virtual Conference
14/08/2024 Q2 2024 Earnings Release (Projected)
12/03/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on RedHill Biopharma Ltd.

08/04/2024 14:23 Q4 2023 Earnings Release
17/08/2023 12:00 Q2 2023 Earnings Release
12/06/2023 13:00 Q1 2023 Earnings Release
04/05/2023 16:00 Aegis Capital Corp Virtual Conference
28/04/2023 12:00 Q4 2022 Earnings Release
29/11/2022 13:00 Q3 2022 Earnings Release
20/11/2022 International Conference on Microbiology & Infectious Diseases
20/10/2022 American College of Gastroenterology Scientific Meeting - Poster No - A089
20/10/2022 American College of Gastroenterology Scientific Meeting - Poster No - A090
20/10/2022 American College of Gastroenterology Scientific Meeting - Poster No - A0683
16/08/2022 Talicia® -World Gastro Congress
06/08/2022 International Conference on Emerging Infectious Diseases
12/07/2022 ARDS Drug Development Summit
23/06/2022 13:30 Q1 2022 Earnings Call
23/06/2022 12:00 Q1 2022 Earnings Release
22/05/2022 H.C. Wainwright Global Life Sciences Investment Conference
20/05/2022 Digestive Diseases Week Conference - Poster Number: Tu1078
20/05/2022 Digestive Diseases Week Conference - poster number: Tu1077
12/05/2022 13:00 Annual General Meeting
28/03/2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
6,29
6,88
-8.55%
64,4
68,1
-5.54%
85,8
87,9
-2.44%
61,8
68,0
-9.12%
EBITDA
Million USD
Released
Forecast
Spread
-42,2
-40,2
-5.05%
-54,9
-48,0
-14.46%
-69,0
-66,0
-4.56%
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-43,2
-42,1
-2.5%
-63,7
-49,9
-27.6%
-81,1
-78,1
-3.92%
-42,8
-29,7
-44.26%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-42,3
-41,3
-2.37%
-76,2
-65,3
-16.73%
-97,7
-95,0
-2.93%
-71,7
-41,1
-74.38%
Net income
Million USD
Released
Forecast
Spread
-42,3
-41,3
-2.37%
-76,2
-65,3
-16.73%
-97,7
-95,0
-2.93%
-71,7
-41,1
-74.38%
EPS
USD
Released
Forecast
Spread
-56,0
-35,3
-58.73%
-84,0
-46,6
-80.41%
-84,0
-39,5
-112.43%
-1,20
-2,80
57.14%
Announcement Date04/03/2018/03/2117/03/2228/04/23

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales
Million USD
Released
Forecast
Spread
22,1
24,1
-8.37%
18,2
23,6
-22.73%
18,3
21,5
-14.68%
17,6
18,5
-5.12%
12,8
18,1
-29.29%
EBITDA
Million USD
Released
Forecast
Spread
-18,4
-15,4
-19.32%
-10,4
-14,4
27.81%









EBIT
Million USD
Released
Forecast
Spread
-20,7
-17,6
-17.5%
-13,2
-15,1
12.33%
-9,16
-6,89
-32.93%
-7,11
-4,20
-69.24%
-9,95
0,30
-3416%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-24,4
-22,0
-10.8%
-17,1
-17,6
2.63%
-11,7
-10,6
-10.4%
-35,7
-7,50
-376.01%
-3,73
-1,40
-166.36%
Net income
Million USD
Released
Forecast
Spread
-24,4
-22,0
-10.8%
-17,1
-17,6
2.63%
-11,7
-10,6
-10.4%
-35,7
-7,50
-376.01%
-3,73
-1,40
-166.36%
EPS
USD
Released
Forecast
Spread
-20,0
-8,34
-139.73%
-1,20
-1,20
0%
-0,80
-0,60
-33.33%
-2,40
-0,40
-500%
0,00
0,00
-
Announcement Date17/03/2223/06/2207/11/2229/11/2228/04/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. RDHL Stock
  5. Calendar RedHill Biopharma Ltd.